Cel-Sci Corporation

Cel-Sci Corporation Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Cel-Sci Corporation, Medical Service, 8229 Boone Boulevard, Suite 802, Vienna, VA.

CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.

CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
09/15/2026

CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology

CEL-SCI invited to deliver keynote address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology.

CEL-SCI Reports Fiscal Third Quarter 2026 Results
08/17/2026

CEL-SCI Reports Fiscal Third Quarter 2026 Results

CEL-SCI reported financial results for three months ended June 30, 2026, as well as key recent corporate and clinical developments for Multikine.

CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Sur...
08/04/2026

CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit

CEL-SCI study published in peer-reviewed Oral Oncology supports Multikine's biomarker strategy and potential overall survival benefit.

CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine to Market for Newly Diagnosed ...
07/13/2026

CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine to Market for Newly Diagnosed Head and Neck Cancer

CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Canc...
06/24/2026

CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care

CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care.

CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market...
06/16/2026

CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy

CEL-SCI advances Multikine immunotherapy for Head and Neck Cancer through dual U.S. registration study and Saudi market entry strategy.

CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization an...
06/12/2026

CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine in Saudi Arabia

CEL-SCI and Saudi Amarox to conduct signing ceremony at BIO 2026 for Strategic Agreement to advance commercialization and distribution of Multikine.

CEL-SCI Reports Fiscal Second Quarter 2026 Results
05/18/2026

CEL-SCI Reports Fiscal Second Quarter 2026 Results

CEL-SCI reported financial results for three months ended March 31, 2026, as well as key corporate developments for Multikine.

CEL-SCI Corporation Announces Pricing of Public Offering
05/12/2026

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Corporation Announces Pricing of Public Offering.

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in...
05/11/2026

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia.

Address

8229 Boone Boulevard, Suite 802
Vienna, VA
22182

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

+17035069460

Alerts

Be the first to know and let us send you an email when Cel-Sci Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share